Tagged Articles

ASR hip replacement system 41 articles

Texas woman sues Depuy over defective double hip implants

A Texas woman who received hip implants made by DePuy Orthopaedics is suing the medical device manufacturer for damages she says she has experienced since undergoing hip implant surgery. The lawsuit, which was filed on July 7 in the Eastern District of Texas, Marshall Division, alleges DePuy misrepresented its ASR XL Acetabular device and claims had the plaintiff known how faulty the hip implants were, she would not have the devices implanted. The plaintiff had the ASR XL Acetabular System implanted in her right hip in July 2009 and in her left hip about seven months later. Shortly after the ... Read More

DePuy hip implant recipient says he can’t remember how pain-free feels

Severe, unceasing pain and immobility has become a new way of life for many patients who received faulty hip implants. Ironically, patients who are experiencing problems with their defective hip implants elected to receive the devices because they thought they would make life better by reducing pain and improving mobility. Norman Sherrington, a 67-year-old U.K. citizen, is one such patient. Speaking on Dispatches, an investigative television program aired in the U.K., Sherrington said that he has endured constant pain ever since his 2006 surgery in which he received a DePuy ASR XL Acetabular (total hip) implant. “I can’t walk up ... Read More

Louisiana hip-implant lawsuit targets DePuy and its distributor

A Louisiana woman has filed a lawsuit in Orleans Parish Civil District Court against DePuy Orthopaedics, alleging her ASR artificial hip implant was defective and shouldn’t have been marketed by DePuy and its parent company Johnson & Johnson, nor distributed by Mark Starring & Associates – a Metairie, Louisiana-based medical supply distributor. According to the Louisiana Record, the plaintiff seeks damages for personal injuries caused by the faulty DePuy implant, which were severe enough to warrant having it removed in a second surgery and replaced with a different device. In addition to the pain and recovery the plaintiff endured, she ... Read More

U.K. DePuy hip patients deal with debilitating pain, long waiting lists

A lawyer representing some 300 recipients of DePuy artificial hips in the U.K. says that for her clients and many other patients throughout the country waiting to have the devices removed, “the damage has already been done.” Liverpool solicitor Lisa Lunt told the Liverpool Daily Post that several of her clients have been so damaged by the recalled hip devices that they will likely never experience the quality of life that the DePuy implants once promised. “The large majority of my clients are really suffering terrible pain, some now have walking aids,” Ms. Lunt told the Liverpool Daily Post. “One ... Read More

Employee benefits fund files suit against artificial hip maker

A fund that manages health benefits for 25 towns in northern New Jersey has filed a civil lawsuit in U.S. District Court alleging that medical device manufacturer DePuy Orthopaedics continued to market its ASR hip replacement system in the United States even after learning that the device was defective and causing patients unnecessary pain and suffering. The North Jersey Municipal Employee Benefits Fund filed the class action lawsuit last month, and is asking the court to order DePuy to cover any of its members who may have been affected by the recall of the faulty device as well as allow the ... Read More

Amid sea of recalls, J and J considers takeover of medical device company

Johnson & Johnson is reportedly in talks with device maker Synthes Inc. about a possible takeover, potentially the biggest deal in Johnson & Johnson’s 125-year history. Synthes has a market value of about $19 billion, and a takeover of the company could give Johnson & Johnson just what it needs deflect the negative press it has received over the past year from recalled products that range from over-the-counter medicines and consumer products to artificial hip implants. Synthes is the largest maker of devices to treat bone fractures and trauma. Merging with Synthes’ Smith & Nephew Plc. would add more trauma products ... Read More

Rate of hospital readmissions increases for artificial hip recipients

The average length of a hospital stay for patients who have hip replacement surgery has dropped considerably in recent years, but the rate of readmissions for complications or referrals to nursing homes has increased, according to a new study. Researchers reviewed 1.5 million Medicare Part A beneficiaries who underwent primary total hip replacement surgery between 1991 and 2008, and 348,596 people who underwent revision surgery, or surgery to replace an artificial hip. The average length of hospital stay for primary hip replacement patients dropped from 9.1 days during the first two years of the study to 3.7 days during the ... Read More

Many medical devices approved without human testing

About one percent of medical devices introduced in the United States market get recalled. It seems like a small number, but that number represents thousands of people who have died or been harmed by faulty medical devices. The clincher? Many of those devices were never tested on humans before they were approved for use. The process is called fast-tracking. Some categories of medical devices can be approved by the Food and Drug Administration (FDA) with little or no testing if they are similar to other devices already approved. Since 2009, 67 individual high-risk devices have been approved through this process ... Read More

DePuy hip implant failure rate may be 4X higher than previously thought

New data suggests that the failure rate of DePuy Orthopaedics ASR hip replacement systems is as much as four times higher than previously thought. The implants were recalled in August 2010 after studies showed that the implants had a failure rate of about 13 percent after five years. Most hip implants have a 13 percent failure rate after about 35 years. The new information comes from the British Orthopaedic Association and the British Hip Society, which said data from four surgeons showed that the rate of revision surgeries to replace defective DePuy artificial hips ranged from 21 percent after four ... Read More

Flaws in FDA standards allowed defective medical devices on market

Only 19 percent of the medical devices recalled between 2005 and 2009 underwent stringent reviews, and only 29 percent had been previously tested on humans, according to a new analysis on how well the Food and Drug Administration (FDA) is doing at protecting Americans from defective medical devices. One hundred and thirteen types of medical devices – from automatic external defibrillators (AEDs) to hip implants – were recalled between 2005 and 2009 because they posed serious and sometimes life threatening health risks. The devices had been approved by the FDA as part of a program that allowed the devices to ... Read More